Aptevo regains Nasdaq compliance with $15.9M equity raise

Aptevo Therapeutics Inc.

Received Nasdaq notice confirming compliance with minimum $2.5M stockholders' equity rule.
Raised ~$15.9M gross proceeds from equity capital in quarter ended June 30, 2025.
Company previously disclosed non-compliance for quarter ended March 31, 2025.
Believes stockholders' equity now exceeds $2.5M threshold.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.